Merck & Co., Inc., Rahway, N.J., USA Announces Third-Quarter 2026 Financial Results; Highlights Multiple Milestones Advancing Broad, Diverse Pipeline

Live updates

1. 1h ago

   Merck & Co. Announces Q3 2026 Financial Results

   Merck & Co., Inc., Rahway, N.J., USA reported Q3 2026 financial results, highlighting $18.1 billion in total worldwide sales, a 5% growth, with key contributions from oncology and animal health products. The company's cancer treatment Keytruda and new product Winrevair showed significant growth. Merck also presented pivotal data from Phase 3 trials across its oncology pipeline at the ESMO Congress 2026.

   Why it matters

   Merck's financial performance reflects its continued strength in oncology and animal health, with a diverse pipeline of products. The company's results are closely watched as they indicate the effectiveness of its business strategy and product portfolio. Merck's growth in these areas is crucial for its long-term success.

   What is confirmed

   • Merck's total worldwide sales were $18.1 billion in Q3 2026, a 5% growth
   • Keytruda sales were $8.6 billion in Q3 2026, a 6% growth
   • Winrevair sales were $694 million in Q3 2026, a 93% growth
   • Merck presented pivotal data from Phase 3 trials across its oncology pipeline at the ESMO Congress 2026

   What to watch next

   • Merck's Q4 2026 financial results
   • Progress of Merck's oncology pipeline
   • Regulatory decisions on new Merck products
   Sources used for this update (16)

   1. www.tradingkey.com — Today’s Market Recap: OpenAI Revenue Concerns; Nasdaq Falls 1.25%, AAOI Drops 13.58%, Brent Gains 4.07%
   2. www.foxnews.com — Ohio 2026 Midterm Election Results
   3. CNBC — Merck tops quarterly estimates, hikes profit outlook as new Keytruda form shows strength
   4. Bloomberg — Merck Boosts Profit Forecast as Key Medicines Top Estimates
   5. Barchart.com — Dear Merck Stock Fans, Mark Your Calendars for October 29
   6. Merck | Home — Merck & Co., Inc., Rahway, N.J., USA Announces Third-Quarter 2026 Financial Results; Highlights Multiple Milestones Advancing Broad, Diverse Pipeline
   7. WSJ — Merck Revenue Up on Keytruda, Winrevair Growth
   8. Merck | Home — Our Q3 2026 financial results
   9. www.merck.com — Merck & Co., Inc., Rahway, N.J., USA Announces Third-Quarter ...
   10. www.motir.go.kr — 글로벌 화학 기업 독일 머크(Merck), 대전 바이오 원부자재 제조 거점 개소 < 보도·참고자료 < 보도....
   11. www.biospace.com — Merck & Co., Inc., Rahway, N.J., USA Announces Third-Quarter ...
   12. www.korea.kr — 글로벌 화학 기업 독일 머크(Merck), 대전 바이오 원부자재 제조 거점 개소 - 보도자료 | 브리핑룸
   confidence 100%